期刊文献+

Ki-67和P21在肾上腺皮质癌中的表达及意义 被引量:3

The expression of Ki-67 and P21 in adrenocortical carcinoma and their significance
下载PDF
导出
摘要 目的 探讨肾上腺皮质癌 (ACC)中Ki 67和P2 1的表达及其意义。方法 采用免疫组化SP法和图像分析技术对 8例正常肾上腺组织、2 0例肾上腺腺瘤 (ACA)、19例肾上腺皮质癌中Ki 67、P2 1进行检测。结果 Ki 67和P2 1的表达在肾上腺腺瘤与肾上腺皮质癌间差异均有统计学意义 (P <0 .0 1,P <0 .0 5 )。Ki 67的表达与肾上腺皮质癌分期、浸润或转移、2年生存情况相关(P <0 .0 1) ,与肿瘤大小无关 (P >0 .0 5 )。P2 1的表达与肾上腺皮质癌的大小、分期、浸润或转移、2年生存情况均无显著相关 (P >0 .0 5 )。结论 Ki 67和P2 1对肾上腺皮质良恶性肿瘤具有重要的鉴别诊断作用 ,Ki 67可作为判断肾上腺皮质癌预后不良的指标。 Objective To study the expression of Ki-67 and P21 in adrenocortical carcinoma and their significance.Methods Ki-67 and P21 were detected by immunohistochemical technique (SP method) and image analysis in 8 cases of normal adrenal,20 cases of adrenocortical adenoma (ACA) and 19 cases of adrenocortical carcinoma(ACC).Results There was statistically significant difference in expressions of Ki-67 and P21 among normal adrenal,adrenocortical adenoma and adrenocortical carcinoma(-P-<0.01,-P-<0.05).There was significant correlation between Ki-67 expression and tumor stage,invasion,metastasis,survival rate of 2 years (-P-<0.01).But there was no relationship between Ki-67 expression and tumor diameter (-P->0.05).There was no significant correlation between P21 expression and tumor diameter,stage,invasion,metastasis,survival rate of 2 years (-P->0.05).Conclusions Immunohistochemical assessment of Ki-67 and p21 can be useful in the differential diagnosis of adrenocortical adenoma and carcinoma.Ki-67 may be served as an unfavorable prognostic marker of adrenocortical carcinoma.
出处 《临床内科杂志》 CAS 北大核心 2004年第12期849-851,共3页 Journal of Clinical Internal Medicine
关键词 肾上腺肿瘤 KI-67 P21 免疫组织化学 Adrenocortical neoplasms Ki-67 P21 Immunohistochemical technique
  • 相关文献

参考文献9

  • 1Hartwell LH,Kastan MB.Cell cycle control and cancer.Science,Science,1994,16(266):1821-1828.
  • 2Weiss LM,Medeiros LJ,Vickery AL.Pathologic features of prognostic significance in adrenocortical carcinoma.Am J Surg Pathol,1989,13(3):202-206.
  • 3Lee JE,Berger DH,el-Naggar,et al.Surgical management,DNA content,and patient survival in adrenal cortical carcinoma.Surgery,1995,118(6):1090-1098.
  • 4Hall PA,Levison DA.Review:assessment of cell proliferation in histological material.J Clin Pathol,1990,43(3):184-192.
  • 5Wachenfeld C,Beuschlein F,Zwermann O,et al.Discerning malignancy in adrenocortical tumors:are molecular markers useful? Eur J Endocrinol,2001,145(3):335-341.
  • 6Terzolo M,Boccuzzi A,Bovio S,et al.Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors.Urology,2001,57(1):176-182.
  • 7Stojadinovic A,Brennan MF,Hoos A,et al.Adrenocortical adenoma and carcinoma:histopathological and molecular comparative analysis.Mod Pathol,2003,16(8):742-751.
  • 8冯华,曹书颖.子宫内膜癌p21和p53蛋白表达的研究[J].实用肿瘤杂志,1999,14(1):30-31. 被引量:2
  • 9Stojadinovic A,Ghossein RA,Hoos A,et al.Adrenocortical carcinoma:clinical,morphologic and molecular characterization.J Clin Oncol,2002,20(4):941-950.

共引文献1

同被引文献53

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部